Medical expertise company RubiconMD on Thursday announced a suite of COVID-19 vaccine eConsults and resources to continue to support the primary care physicians deliver the clear, accurate communication vital in the fight against the pandemic.
RubiconMD's panel of COVID-19 vaccine experts will review the real eConsult case studies and leverage educational resources curated in partnership with CONVINCE USA Initiative at the CUNY Graduate School of Public Health and Health Policy.
Based on the survey of RubiconMD clinicians, about 50% of respondents felt that they do not have all the resources needed to make vaccine decisions to adequately address patient questions. Respondents strongly emphasized the need for digestible summaries of vaccine recommendations, clinical guidelines for patients with complex conditions, and multilingual patient-facing resources.
Following the feedback, RubiconMD encourages clinicians to reach out to their specialist experts with any vaccine questions and leverage the dashboard for continually updated curated content and CME eligible webinars.
Merck launches Phase 3 trial for dengue vaccine candidate V181
BioNet and Bio Farma sign MoU on TdaP vaccine
Dx&Vx accelerates universal COVID-19 vaccine development
Moderna withdraws application for flu-COVID combination vaccine pending additional efficacy data
CTP delivers 18,000 sqm Serbian facility for SCHOTT Pharma to support global expansion
LakeShore Biopharma launches novel packaging solution for YSJA rabies vaccine (Vero cell)
Scancell partners with NHS Cancer Vaccine Launch Pad to accelerate melanoma trial recruitment
Orexo reports positive results for powder-based intranasal vaccine using AmorphOX technology
GC Biopharma's BARYTHRAX receives Korean regulatory approval
GSK grants USD2m to boost adult vaccination efforts
Valneva and LimmaTech begin Phase 2 infant trial for Shigella vaccine candidate S4V2
Circio Holding and Entos Pharmaceuticals collaborate on circular RNA delivery
AKAGERA Medicines completes first cohort in phase 1 SAD/MAD study of AKG-100